Assertio Holdings, Inc. (ASRT)
22.30
+0.10
(+0.45%)
USD |
NASDAQ |
May 07, 14:30
Assertio Holdings Cash from Investing (Quarterly) : 1.699M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Castle Biosciences, Inc. | 8.831M |
| ANI Pharmaceuticals, Inc. | -1.403M |
| Catalyst Pharmaceuticals, Inc. | -0.032M |
| Aura Biosciences, Inc. | 29.82M |
| Plus Therapeutics, Inc. | -1.077M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -29.97M |
| Cash from Financing (Quarterly) | -0.002M |
| Free Cash Flow | -28.18M |
| Free Cash Flow Per Share (Quarterly) | -4.668 |
| Free Cash Flow to Equity (Quarterly) | -25.25M |
| Free Cash Flow to Firm (Quarterly) | -29.18M |
| Free Cash Flow Yield | -4.37% |